StonvexLoading…
StonvexStonvexStonvexCore line items from ALCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $44.07M | $46.64M | $39.85M | $91.95M |
Operating Income | $-203.90M | $-67.45M | $-4.20M | $-24.84M |
Net Income | $-147.33M | $6.97M | $1.83M | $12.46M |
EPS (Diluted) | $-19.29 | $0.91 | $0.24 | $1.65 |
Total Assets | $201.53M | $398.72M | $428.35M | $409.25M |
Total Liabilities | $93.53M | $142.42M | $177.98M | $160.39M |
Cash & Equivalents | $38.13M | $3.15M | $1.06M | $865.00K |
Free Cash Flow OCF − CapEx | $14.62M | $-48.37M | $-22.91M | $-14.21M |
Shares Outstanding | 7.65M | 7.63M | 7.61M | 7.59M |